Quarterly report pursuant to Section 13 or 15(d)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v2.4.0.8
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]            
Research and Development Expense $ 99,893 $ 178,507 $ 222,044 $ 484,846    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 2,990,977   2,990,977     2,990,977
Registration Payment Arrangement, Accrual Carrying Value $ 55,620   $ 55,620   $ 48,668  
Employee Stock Option [Member]
           
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 2,990,977   2,990,977      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in Shares)     1,904,659